Solvay Pharmaceuticals, Inc. Raises Innogenetics Bid, Beats off Gen-Probe Incorporated
BRUSSELS, July 9 (Reuters) - Belgian drugmaker Solvay increased its bid for biotech company Innogenetics on Wednesday, beating off a rival offer from U.S. disease diagnosis firm Gen-Probe Inc.